Literature DB >> 20069393

HLA-A and breast cancer in West Peninsular Malaysia.

Pooi Pooi Leong1, Rohaizak Muhammad, Naqiyah Ibrahim, Soon Keng Cheong, Heng Fong Seow.   

Abstract

Breast cancer is the most common malignancy among females in Malaysia. Attempts have been made to investigate the association between breast cancer and human leukocyte antigen (HLA) types. However, data from those previous studies are highly variable. The aim of this study is to investigate the association between HLA-A types and clinicopathological factors in breast cancer. The frequencies of HLA-A type in 59 female patients with infiltrating ductal of the breast were determined by polymerase chain reaction method. HLA-A2/A30 and A2/A31 haplotype (5.1%; P = 0.045) as well as HLA-A30 (5.1%, P = 0.045) and A31 (6.8%; P = 0.020) allele were significant higher in the patients than controls (0%). HLA-A24 allele was negatively related to lymph node metastasis (r = -0.316; P = 0.021) whereas, A26 (r = -0.430; P = 0.001) and A36 (r = -0.430; P = 0.001) alleles were negatively correlated to distant metastasis in breast cancer. Negative correlations between HLA-A26/A36 (r = -0.430; P = 0.001), A2/A11 (r = -0.276; P = 0.044), A24/A34 (r = -0.430; P = 0.001) haplotypes and distant metastasis were identified. Interestingly, Her2 expression in breast carcinoma was negatively correlated to A11/24 haplotypes (r = -0.294; P = 0.034) but positively correlated to homozygous HLA-A24 (r = 0.396; P = 0.040). In conclusion, HLA-A2, -A30 and A31 were associated with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20069393     DOI: 10.1007/s12032-009-9414-6

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  38 in total

1.  Is there a relationship between HLA type and prognostic factors in breast cancer?

Authors:  C Gourley; C Thornton; C Massie; R J Prescott; M Turner; R C F Leonard; D C Kilpatrick
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

Review 2.  Could TCR antagonism explain associations between MHC genes and disease?

Authors:  Stanislav Vukmanović; Thomas A Neubert; Fabio R Santori
Journal:  Trends Mol Med       Date:  2003-04       Impact factor: 11.951

3.  Delay in breast cancer care: a study in Thai women.

Authors:  P Thongsuksai; V Chongsuvivatwong; H Sriplung
Journal:  Med Care       Date:  2000-01       Impact factor: 2.983

4.  Breast cancer in Iran: a review of 903 case records.

Authors:  I Harirchi; M Ebrahimi; N Zamani; S Jarvandi; A Montazeri
Journal:  Public Health       Date:  2000-03       Impact factor: 2.427

5.  Breast carcinoma in Pakistani women.

Authors:  K Usmani; A Khanum; H Afzal; N Ahmad
Journal:  J Environ Pathol Toxicol Oncol       Date:  1996       Impact factor: 3.567

6.  Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus.

Authors:  N C Cheng; M Beitsma; A Chan; I Op den Camp; A Westerveld; J Pronk; R Versteeg
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

7.  Brain glioma and human leukocyte antigens (HLA)--is there an association.

Authors:  H K Machulla; F Steinborn; A Schaaf; V Heidecke; N G Rainov
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

8.  Human leukocyte antigens and multiple basal cell carcinomas.

Authors:  R Rompel; J Petres; K Kaupert; G Müller-Eckhardt
Journal:  Recent Results Cancer Res       Date:  1995

9.  Human leucocytic antigens (HLA) in breast cancer.

Authors:  B M Biswal; R Kumar; P K Julka; U Sharma; M C Vaidya
Journal:  Indian J Med Sci       Date:  1998-05

10.  HLA-A2 expression, stage, and survival in colorectal cancer.

Authors:  Philipp Kiewe; Veit Mansmann; Carmen Scheibenbogen; Heinz-Johannes Buhr; Eckhard Thiel; Dirk Nagorsen
Journal:  Int J Colorectal Dis       Date:  2008-05-07       Impact factor: 2.571

View more
  1 in total

1.  Relevance of the MHC region for breast cancer susceptibility in Asians.

Authors:  Mikael Hartman; Jingmei Li; Peh Joo Ho; Alexis Jiaying Khng; Benita Kiat-Tee Tan; Ern Yu Tan; Su-Ming Tan; Veronique Kiak Mien Tan; Geok Hoon Lim; Kristan J Aronson; Tsun L Chan; Ji-Yeob Choi; Joe Dennis; Weang-Kee Ho; Ming-Feng Hou; Hidemi Ito; Motoki Iwasaki; Esther M John; Daehee Kang; Sung-Won Kim; Allison W Kurian; Ava Kwong; Artitaya Lophatananon; Keitaro Matsuo; Nur Aishah Mohd-Taib; Kenneth Muir; Rachel A Murphy; Sue K Park; Chen-Yang Shen; Xiao-Ou Shu; Soo Hwang Teo; Qin Wang; Taiki Yamaji; Wei Zheng; Manjeet K Bolla; Alison M Dunning; Douglas F Easton; Paul D P Pharoah
Journal:  Breast Cancer       Date:  2022-05-11       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.